Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis (Nature Communications, (2024), 15, 1, (9400), 10.1038/s41467-024-53273-7)

  • AIDS Clinical Trial Group
  • , Tuberculosis Trials Consortium
  • University of California San Francisco Center for Tuberculosis
  • University of California San Francisco
  • Centers for Disease Control and Prevention
  • University of Nebraska Medical Center
  • Johns Hopkins University School of Medicine
  • Medical University of South Carolina
  • Case Western Reserve University
  • Uganda–Case Western Reserve University Research Collaboration
  • University of Texas
  • St George's University of London
  • Vanderbilt University
  • Cape Town
  • Vietnam National Tuberculosis Program–University of California
  • National Lung Hospital
  • University of Cape Town Lung Institute
  • Vanderbilt University School of Medicine
  • AIDS Clinical Trials Group Operation Center
  • Amherst
  • Hospital Conceicao
  • Chiang Mai University
  • Thai Red Cross AIDS Research Centre
  • Kenya Medical Research Institute
  • Universidad Peruana Cayetano Heredia
  • Asoc. Civ. Impacta Salud y Educ.
  • San Miguel Clinical Research Site
  • Moi University
  • Durban International Clinical Research Site
  • Stellenbosch University
  • Johns Hopkins Research Project
  • Oswaldo Cruz Foundation
  • Kisumu Clinical Research Site
  • UNC Project-Malawi
  • Byramjee Jeejeebhoy Medical College
  • Soweto ACTG Clinical Research Site
  • University of the Witwatersrand, Johannesburg
  • Groupe Haïtien d'Etude du Sarcome de Kaposi et des Infections Opportunistes
  • South African Tuberculosis Vaccine Initiative
  • Parirenyatwa Clinical Research Site
  • Baylor College of Medicine
  • Austin Tuberculosis Clinic
  • Columbia University
  • University of North Texas Health Science Center at Fort Worth
  • Tuberculosis and Chest Service of Hong Kong

Producción científica: Contribución a una revistaComentario/Debate

Resumen

Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-53273-7, published online 30 October 2024 In the version of the article initially published, Amina Jindani and Thomas Harrison (both St. George’s, University of London, London, UK) were missing from the author list and have now been added. Additionally, the text “We thank Daniel Grint and the RIFASHORT team for providing us access to the data for external validation” was missing from the Acknowledgements section and has now been added. These corrections have been made to the HTML and PDF versions of the article.

Idioma originalInglés
Número de artículo4438
PublicaciónNature Communications
Volumen16
N.º1
DOI
EstadoPublicada - dic. 2025

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

  1. ODS 3: Salud y bienestar
    ODS 3: Salud y bienestar

Huella

Profundice en los temas de investigación de 'Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis (Nature Communications, (2024), 15, 1, (9400), 10.1038/s41467-024-53273-7)'. En conjunto forman una huella única.

Citar esto